| 제품명 | Canagliflozin |
|---|---|
| CAS 번호 | 842133-18-0 |
| 분자식 | C24H25FO5S |
| 분자량 | 444.52 |
| 외관 | 흰색에서 미백색의 결정성 분말 |
| 분석법 (HPLC) | ≥98% |
| 건조 손실 | ≤0.5% |
| 소각 잔류물 | ≤0.1% |
| 중금속 | ≤10 ppm |
| 융점 | 150-155°C (dec.) |
| 특정 회전 | N/A (racemic mixture) |
도움이 필요하신가요? 저희 팀에 문의해 주세요

Canagliflozin is the market leader in the SGLT2 inhibitor class, and it’s easy to see why: it doesn’t just lower blood sugar, it does it by sending excess glucose out through the urine, bypassing insulin entirely. That makes it a powerful tool for type 2 diabetes management, with the added perk of promoting modest weight loss and blood pressure reduction. For formulators, that’s a compelling story to tell — and a product that practically sells itself.
We supply canagliflozin as a high-purity crystalline powder, rigorously tested to meet pharmacopoeial standards. Every batch ships with a full COA, and we offer flexible packaging from 100g R&D quantities to multi-kilogram production lots. Our lead times are fast — typically 7-10 days after order — and we deliver worldwide, so you can keep your supply chain moving without a hitch.